QINGDAO PORT (06198) increased capital by US$9.6 million to Gusheng Holdings in proportion to its shareholding
QINGDAO PORT (06198) announced that on October 29, 2026 (after trading hours), Gusheng Holdings entered into a capital increase agreement with its shareholder Qinggang Logistics, a wholly-owned subsidiary of the Company, Qingdao Port Hong Kong Company, and Shandong Port Group, Overseas Group, Gangxin Yida, and the Trading Company, pursuant to which the six shareholders intend to jointly increase the capital of Gusheng Holdings by US$30 million in cash in proportion to their existing shareholdings, with Qinggang Logistics and Qingdao Port Hong Kong Company contributing US$6.6 million and US$3 million respectively. Before completion of this capital increase, the Company indirectly held 32% equity interest in Gusheng Holdings through Qinggang Logistics and Qingdao Port Hong Kong Company, and its financial statements were not consolidated into the Group's consolidated financial statements. After completion of this capital increase, the Company's shareholding ratio in Gusheng Holdings remains unchanged.
QINGDAO PORT (06198) announced that on October 29, 2026 (after trading hours), Gusheng Holdings entered into a capital increase agreement with its shareholder the company's wholly-owned subsidiary Qinggang Logistics, QINGDAO PORT Hong Kong Company, and Shandong Port Group, Overseas Group, Gangxin Yida, and the Trading Company, pursuant to which the six shareholders intend to jointly increase the capital of Gusheng Holdings by US$30 million in cash in proportion to their existing shareholdings, with Qinggang Logistics and QINGDAO PORT Hong Kong Company contributing US$6.6 million and US$3 million respectively. Before the completion of this capital increase, the company indirectly held 32% equity interest in Gusheng Holdings through Qinggang Logistics and QINGDAO PORT Hong Kong Company, and its financial statements were not consolidated into the group's consolidated financial statements. After the completion of this capital increase, the company's shareholding ratio in Gusheng Holdings remains unchanged.
The announcement stated that this capital increase is primarily to provide funding support for Gusheng Holdings' potential investment projects and business expansion, which will help the company improve its overseas service network through the Gusheng Holdings platform and promote the extension of the company's port service capabilities to key overseas business regions, in line with the company's overall strategic planning.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process

Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares

CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%
Jiangsu Hengrui Pharmaceuticals (01276): Marketing authorization application for trastuzumab rezetecan for injection accepted and included in priority review process

Hua Hong Grace Semiconductor (01347): Chairman and President proposes share repurchase of the company's A-shares

CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit for the first three quarters was RMB60.5883 million, a year-on-year decrease of 82.34%






